Inhibition of son of sevenless homologue 1 (SOS1): promising therapeutic treatment for KRAS-mutant cancers
T Chen, X Tang, Z Wang, F Feng, C Xu, Q Zhao… - European Journal of …, 2023 - Elsevier
Kristen rat sarcoma (KRAS) is one of the most common oncogenes in human cancers. As a
guanine nucleotide exchange factor, Son of Sevenless Homologue 1 (SOS1) represents a …
guanine nucleotide exchange factor, Son of Sevenless Homologue 1 (SOS1) represents a …
Design and discovery of MRTX0902, a potent, selective, brain-penetrant, and orally bioavailable inhibitor of the SOS1: KRAS protein–protein interaction
JM Ketcham, J Haling, S Khare, V Bowcut… - Journal of Medicinal …, 2022 - ACS Publications
SOS1 is one of the major guanine nucleotide exchange factors that regulates the ability of
KRAS to cycle through its “on” and “off” states. Disrupting the SOS1: KRASG12C protein …
KRAS to cycle through its “on” and “off” states. Disrupting the SOS1: KRASG12C protein …
[HTML][HTML] Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics
R Kumar, N Mishra, T Tran, M Kumar… - Cells, 2024 - mdpi.com
Cardiovascular diseases continue to challenge global health, demanding innovative
therapeutic solutions. This review delves into the transformative role of mesenchymal stem …
therapeutic solutions. This review delves into the transformative role of mesenchymal stem …
Comparative analysis of human induced pluripotent stem cell‐derived mesenchymal stem cells and umbilical cord mesenchymal stem cells
S Rajasingh, V Sigamani, V Selvam… - Journal of Cellular …, 2021 - Wiley Online Library
Generation of induced pluripotent stem cells (iPSCs) and their differentiation into
mesenchymal stem/stromal cells (iMSCs) have created exciting source of cells for …
mesenchymal stem/stromal cells (iMSCs) have created exciting source of cells for …
Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c. 1824 C> T
Cardiovascular diseases, atherosclerosis, and strokes are the most common causes of
death in patients with Hutchinson-Gilford progeria syndrome (HGPS). The LMNA variant c …
death in patients with Hutchinson-Gilford progeria syndrome (HGPS). The LMNA variant c …
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer
D Alem, X Yang, F Beato, B Sarcar… - Molecular …, 2023 - Wiley Online Library
It has been challenging to target mutant KRAS (mKRAS) in colorectal cancer (CRC) and
other malignancies. Recent efforts have focused on developing inhibitors blocking …
other malignancies. Recent efforts have focused on developing inhibitors blocking …
scaRNA20 promotes pseudouridylatory modification of small nuclear snRNA U12 and improves cardiomyogenesis
S Perales, V Sigamani, S Rajasingh… - Experimental Cell …, 2024 - Elsevier
Non-coding RNAs, particularly small Cajal-body associated RNAs (scaRNAs), play a
significant role in spliceosomal RNA modifications. While their involvement in ischemic …
significant role in spliceosomal RNA modifications. While their involvement in ischemic …
[HTML][HTML] In-silico and in-vitro analysis of human SOS1 protein causing noonan Syndrome-a novel approach to explore the molecular pathways
Aims Perform in-silico analysis of human SOS1 mutations to elucidate their pathogenic role
in Noonan syndrome (NS). Background NS is an autosomal dominant genetic disorder …
in Noonan syndrome (NS). Background NS is an autosomal dominant genetic disorder …
Translational potential of hiPSCs in predictive modeling of heart development and disease
Congenital heart disease (CHD) represents a major class of birth defects worldwide and is
associated with cardiac malformations that often require surgical intervention immediately …
associated with cardiac malformations that often require surgical intervention immediately …
The translational role of SOS1 in colorectal cancer
Background It has been challenging to develop agents directly targeting KRAS driver
mutations in colorectal cancer (CRC). Recent efforts have focused on developing inhibitors …
mutations in colorectal cancer (CRC). Recent efforts have focused on developing inhibitors …